Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen…
The post New patent expiration for Teva Pharm drug AIRDUO RESPIC…
New patent expiration for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Annual Drug Patent Expirations for ACTONEL Actonel is a drug marketed by Apil and Warner Chilcott and is included in two NDAs. It is available from two suppliers. There are…
The post New patent expiration for APIL drug ACTONEL appeared first on DrugPat…
Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-five…
The post New patent expiration for Teva Pharm drug ARMONAIR …
New patent expiration for Teva Pharm drug ARMONAIR DIGIHALER Read Post »
Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Teva Pharm drug ARMONAIR R…
New patent expiration for Teva Pharm drug ARMONAIR RESPICLICK Read Post »
Annual Drug Patent Expirations for AIRDUO+DIGIHALER Airduo Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are twenty-eight…
The post New patent expiration for Teva Pharm drug AIRDUO DIG…
New patent expiration for Teva Pharm drug AIRDUO DIGIHALER Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared firs…
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent expiration for Alnylam Pharms drug ONPATTRO appeared fir…
New patent expiration for Alnylam Pharms drug ONPATTRO Read Post »
ONPATTRO (patisiran sodium) Alnylam pharms inc Patent: 9,943,538 Expiration: Nov 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for…
Drug Patent Expirations for the Week of October 29, 2023 Read Post »
Annual Drug Patent Expirations for OZURDEX Ozurdex is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent expiration for Abbvie drug OZURDEX appeared first on …
Annual Drug Patent Expirations for RYZOLT Ryzolt is a drug marketed by Purdue Pharma and is included in one NDA. There is one patent protecting this drug and one Paragraph…
The post New patent expiration for Purdue Pharma drug RYZOLT appeared first on …
New patent expiration for Purdue Pharma drug RYZOLT Read Post »